HealthDay (9/21, Gordon) reports, “The asthma medication Singulair (montelukast) appears linked to neuropsychiatric side effects, such as depression, aggression, nightmares and headaches,” researchers concluded after analyzing data from the Netherlands Pharmacovigilance Center Lareb database and the World Health Organization’s VigiBase. The findings were published online Sept. 20 in Pharmacology Research and Perspectives. Medscape(9/20, Hackethal) also covers the study.
Related Links:
— “Asthma Drug Tied to Nightmares, Depression,” Serena Gordon, HalthDay, September 21, 2017.